{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T10:29:58Z","timestamp":1793788198759,"version":"4.6.1"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T00:00:00Z","timestamp":1785888000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100005646","name":"Actelion Ltd","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005646","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006396","name":"Alexion Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006396","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jhltopen.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JHLT Open"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.jhlto.2026.100661","type":"journal-article","created":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T15:43:39Z","timestamp":1786549419000},"page":"100661","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["The association between soluble ST2 and transplant-free survival in precapillary pulmonary hypertension"],"prefix":"10.1016","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6934-8545","authenticated-orcid":false,"given":"H\u00e5vard","family":"Ravnestad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7086-6262","authenticated-orcid":false,"given":"Salaheldin","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0132-3023","authenticated-orcid":false,"given":"Charlotte M.","family":"\u00d8stby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Einar","family":"Gude","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5648-7688","authenticated-orcid":false,"given":"John-Peder Escobar","family":"Kvitting","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaspar","family":"Broch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7207-2407","authenticated-orcid":false,"given":"Annika E.","family":"Michelsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thor","family":"Ueland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00f6ran","family":"R\u00e5degran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arne K.","family":"Andreassen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jhlto.2026.100661_bib1","doi-asserted-by":"crossref","DOI":"10.1002\/pul2.12190","article-title":"Societal costs associated with pulmonary arterial hypertension: a study utilizing linked national registries","volume":"13","author":"Runheim","year":"2023","journal-title":"Pulm Circ"},{"key":"10.1016\/j.jhlto.2026.100661_bib2","doi-asserted-by":"crossref","unstructured":"Global, regional, and national burden of pulmonary arterial hypertension, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet Respir Med. 2025;13(1):69\u201379.","DOI":"10.3389\/fpubh.2025.1516365"},{"issue":"6","key":"10.1016\/j.jhlto.2026.100661_bib3","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02024-2021","article-title":"Temporal trends in pulmonary arterial hypertension: results from the COMPERA registry","volume":"59","author":"Hoeper","year":"2022","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jhlto.2026.100661_bib4","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehac237","article-title":"2022 ESC\/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension","author":"Humbert","year":"2022","journal-title":"Eur Heart J"},{"issue":"4","key":"10.1016\/j.jhlto.2026.100661_bib5","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01323-2024","article-title":"Risk stratification and treatment goals in pulmonary arterial hypertension","volume":"64","author":"Dardi","year":"2024","journal-title":"Eur Respir J"},{"issue":"11","key":"10.1016\/j.jhlto.2026.100661_bib6","doi-asserted-by":"crossref","first-page":"e73","DOI":"10.1016\/j.healun.2025.04.015","article-title":"International Society for Heart and Lung Transplantation (ISHLT) Consensus Statement on risk stratification in pulmonary arterial hypertension","volume":"44","author":"Sahay","year":"2025","journal-title":"J Heart Lung Transplant"},{"issue":"7, Supplement","key":"10.1016\/j.jhlto.2026.100661_bib7","doi-asserted-by":"crossref","first-page":"3B","DOI":"10.1016\/j.amjcard.2015.01.034","article-title":"The Biology of ST2: The International ST2 Consensus Panel","volume":"115","author":"Pascual-Figal","year":"2015","journal-title":"Am J Cardiol"},{"issue":"6","key":"10.1016\/j.jhlto.2026.100661_bib8","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1172\/JCI30634","article-title":"IL-33 and ST2 comprise a critical biomechanically induced and cardioprotective signaling system","volume":"117","author":"Sanada","year":"2007","journal-title":"J Clin Invest"},{"issue":"6","key":"10.1016\/j.jhlto.2026.100661_bib9","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1161\/CIRCHEARTFAILURE.109.873240","article-title":"Interleukin-33 prevents apoptosis and improves survival after experimental myocardial infarction through ST2 signaling","volume":"2","author":"Seki","year":"2009","journal-title":"Circ Heart Fail"},{"issue":"11","key":"10.1016\/j.jhlto.2026.100661_bib10","doi-asserted-by":"crossref","DOI":"10.3390\/jcdd10110468","article-title":"Soluble ST2 in heart failure: a clinical role beyond B-type natriuretic peptide","volume":"10","author":"Riccardi","year":"2023","journal-title":"J Cardiovasc Dev Dis"},{"issue":"17","key":"10.1016\/j.jhlto.2026.100661_bib11","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1016\/j.jacc.2019.08.1039","article-title":"Clinical and prognostic significance of sST2 in heart failure","volume":"74","author":"Aimo","year":"2019","journal-title":"JACC"},{"issue":"10","key":"10.1016\/j.jhlto.2026.100661_bib12","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0110976","article-title":"The prognostic value of plasma soluble ST2 in hospitalized Chinese patients with heart failure","volume":"9","author":"Zhang","year":"2014","journal-title":"PloS one"},{"issue":"3-4","key":"10.1016\/j.jhlto.2026.100661_bib13","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1080\/1354750X.2016.1278266","article-title":"Soluble ST2 is associated with disease severity in arrhythmogenic right ventricular cardiomyopathy","volume":"22","author":"Broch","year":"2017","journal-title":"Biomarkers"},{"issue":"2","key":"10.1016\/j.jhlto.2026.100661_bib14","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1016\/j.ijcard.2012.12.031","article-title":"Serum soluble ST2 and interleukin-33 levels in patients with pulmonary arterial hypertension","volume":"168","author":"Carlomagno","year":"2013","journal-title":"Int J Cardiol"},{"issue":"10","key":"10.1016\/j.jhlto.2026.100661_bib15","doi-asserted-by":"crossref","DOI":"10.3390\/jcm8101517","article-title":"The prognostic value of soluble ST2 in adults with pulmonary hypertension","volume":"8","author":"Geenen","year":"2019","journal-title":"J Clin Med"},{"issue":"6","key":"10.1016\/j.jhlto.2026.100661_bib16","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1016\/j.chest.2019.12.037","article-title":"Noninvasive prognostic biomarkers for left-sided heart failure as predictors of survival in pulmonary arterial hypertension","volume":"157","author":"Simpson","year":"2020","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.jhlto.2026.100661_bib17","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1183\/09031936.00049312","article-title":"Risk factors and basic mechanisms of chronic thromboembolic pulmonary hypertension: a current understanding","volume":"41","author":"Lang","year":"2013","journal-title":"Eur Respir J"},{"issue":"5","key":"10.1016\/j.jhlto.2026.100661_bib18","first-page":"1442","article-title":"Soluble ST2 protein as a new biomarker in patients with precapillary pulmonary hypertension","volume":"20","author":"Banaszkiewicz","year":"2024","journal-title":"Arch Med Sci"},{"issue":"10","key":"10.1016\/j.jhlto.2026.100661_bib19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0003331","article-title":"The IL-1-like cytokine IL-33 is constitutively expressed in the nucleus of endothelial cells and epithelial cells in vivo: a novel 'alarmin'?","volume":"3","author":"Moussion","year":"2008","journal-title":"PloS one"},{"issue":"1","key":"10.1016\/j.jhlto.2026.100661_bib20","doi-asserted-by":"crossref","DOI":"10.3390\/cells11010107","article-title":"IL-33, an Alarmin of the IL-1 family involved in allergic and non allergic inflammation: focus on the mechanisms of regulation of its activity","volume":"11","author":"Cayrol","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.jhlto.2026.100661_bib21","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.3389\/fimmu.2018.02432","article-title":"IL-33\/ST2 axis in organ fibrosis","volume":"9","author":"Kotsiou","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.jhlto.2026.100661_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbrc.2024.150750","article-title":"Characterization of long-term interleukin-33 administration as an animal model of pulmonary arterial hypertension","volume":"734","author":"Ikutani","year":"2024","journal-title":"Biochem Biophys Res Commun"},{"issue":"7","key":"10.1016\/j.jhlto.2026.100661_bib23","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.90721","article-title":"Prolonged activation of IL-5-producing ILC2 causes pulmonary arterial hypertrophy","volume":"2","author":"Ikutani","year":"2017","journal-title":"JCI Insight"},{"key":"10.1016\/j.jhlto.2026.100661_bib24","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.ebiom.2018.06.003","article-title":"IL-33 initiates vascular remodelling in hypoxic pulmonary hypertension by up-regulating HIF-1\u03b1 and VEGF expression in vascular endothelial cells","volume":"33","author":"Liu","year":"2018","journal-title":"EBioMedicine"},{"issue":"9","key":"10.1016\/j.jhlto.2026.100661_bib25","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.cardfail.2008.06.415","article-title":"Serial sampling of ST2 predicts 90-day mortality following destabilized heart failure","volume":"14","author":"Boisot","year":"2008","journal-title":"J Card Fail"},{"issue":"18","key":"10.1016\/j.jhlto.2026.100661_bib26","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1016\/j.jacc.2008.07.042","article-title":"Characteristics of the novel interleukin family biomarker ST2 in patients with acute heart failure","volume":"52","author":"Rehman","year":"2008","journal-title":"JACC"},{"issue":"7, Supplement","key":"10.1016\/j.jhlto.2026.100661_bib27","doi-asserted-by":"crossref","first-page":"64B","DOI":"10.1016\/j.amjcard.2015.01.043","article-title":"ST2 and patient prognosis in chronic heart failure","volume":"115","author":"Bayes-Genis","year":"2015","journal-title":"Am J Cardiol"},{"issue":"7, Supplement","key":"10.1016\/j.jhlto.2026.100661_bib28","doi-asserted-by":"crossref","first-page":"26B","DOI":"10.1016\/j.amjcard.2015.01.037","article-title":"ST2 and prognosis in acutely decompensated heart failure: The International ST2 Consensus Panel","volume":"115","author":"Januzzi","year":"2015","journal-title":"Am J Cardiol"},{"issue":"3","key":"10.1016\/j.jhlto.2026.100661_bib29","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1093\/eurjhf\/hfs006","article-title":"Soluble ST2 is associated with adverse outcome in patients with heart failure of ischaemic aetiology","volume":"14","author":"Broch","year":"2012","journal-title":"Eur J Heart Fail"},{"issue":"12","key":"10.1016\/j.jhlto.2026.100661_bib30","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.118.005488","article-title":"Pulmonary production of soluble ST2 in heart failure","volume":"11","author":"Pascual-Figal","year":"2018","journal-title":"Circ Heart Fail"},{"issue":"25","key":"10.1016\/j.jhlto.2026.100661_bib31","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1016\/j.jacc.2008.09.027","article-title":"Nonmyocardial production of ST2 protein in human hypertrophy and failure is related to diastolic load","volume":"52","author":"Bartunek","year":"2008","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"10.1016\/j.jhlto.2026.100661_bib32","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1002\/clc.22262","article-title":"Plasma soluble ST2 levels correlate with disease severity and predict clinical worsening in patients with pulmonary arterial hypertension","volume":"37","author":"Zheng","year":"2014","journal-title":"Clin Cardiol"},{"issue":"4","key":"10.1016\/j.jhlto.2026.100661_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.healun.2013.01.025","article-title":"Mode of death in patients with pulmonary arterial hypertension","volume":"32","author":"Vizza","year":"2013","journal-title":"J Heart Lung Transplant"},{"issue":"3","key":"10.1016\/j.jhlto.2026.100661_bib34","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1164\/rccm.201209-1640OC","article-title":"Causes and circumstances of death in pulmonary arterial hypertension","volume":"188","author":"Tonelli","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"issue":"9","key":"10.1016\/j.jhlto.2026.100661_bib35","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1161\/CIRCULATIONAHA.115.016522","article-title":"Long-term outcome of patients with chronic thromboembolic pulmonary hypertension: results from an International Prospective Registry","volume":"133","author":"Delcroix","year":"2016","journal-title":"Circulation"},{"issue":"12","key":"10.1016\/j.jhlto.2026.100661_bib36","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1016\/j.healun.2020.09.011","article-title":"Idiopathic pulmonary arterial hypertension phenotypes determined by cluster analysis from the COMPERA registry","volume":"39","author":"Hoeper","year":"2020","journal-title":"J Heart Lung Transplant"},{"issue":"18","key":"10.1016\/j.jhlto.2026.100661_bib37","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1136\/heartjnl-2024-324237","article-title":"Low diffusing capacity for carbon monoxide in chronic thromboembolic pulmonary hypertension: a biomarker for microvascular disease?","volume":"110","author":"Gerges","year":"2024","journal-title":"Heart"}],"container-title":["JHLT Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950133426001825?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950133426001825?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T10:09:37Z","timestamp":1793786977000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2950133426001825"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":37,"alternative-id":["S2950133426001825"],"URL":"https:\/\/doi.org\/10.1016\/j.jhlto.2026.100661","relation":{},"ISSN":["2950-1334"],"issn-type":[{"value":"2950-1334","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The association between soluble ST2 and transplant-free survival in precapillary pulmonary hypertension","name":"articletitle","label":"Article Title"},{"value":"JHLT Open","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhlto.2026.100661","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of International Society for Heart and Lung Transplantation.","name":"copyright","label":"Copyright"}],"article-number":"100661"}}